Several authors have shown that VEGF and bFGF serum levels are higher in B-CLL patients than in normal subjects [9,10,11,12], and that all three VEGF receptors are expressed in B-CLL cells [13]. Here, FGF2 is linked to B-cell chronic lymphocytic leukemia.